158 related articles for article (PubMed ID: 31557759)
1. Experiences of Adults Using Continuous Subcutaneous Insulin Infusion: A Qualitative Study.
Mesbah NI; Taha NA; Rahme ZN; Sukkar FF; Omar DM
Med Princ Pract; 2020; 29(3):255-261. PubMed ID: 31557759
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
; Nicolucci A; Maione A; Franciosi M; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E
Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
4. Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injection.
Franciosi M; Maione A; Pomili B; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E; Nicolucci A
Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):7-14. PubMed ID: 19747804
[TBL] [Abstract][Full Text] [Related]
5. WHICH FACTORS MAY AFFECT THE QUALITY OF LIFE IN PATIENTS WITH TYPE 1 DIABETES MELLITUS USING THE MEDTRONIC VEO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION PUMP?
Thomakos P; Panagopoulos G; Kepaptsoglou O; Zoupas C; Mitrakou A
Georgian Med News; 2018 Apr; (277):61-67. PubMed ID: 29745917
[TBL] [Abstract][Full Text] [Related]
6. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
Potti LG; Haines ST
J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
[TBL] [Abstract][Full Text] [Related]
7. Barriers and facilitators to accessing insulin pump therapy by adults with type 1 diabetes mellitus: a qualitative study.
Gajewska KA; Biesma R; Bennett K; Sreenan S
Acta Diabetol; 2021 Jan; 58(1):93-105. PubMed ID: 32862261
[TBL] [Abstract][Full Text] [Related]
8. [Satisfaction and quality of life evaluation in patients with type 1 diabetes mellitus treated using continuous subcutaneous insulin infusion compared with multiple daily injections].
Lozano-Serrano M; García-Seco JA; García-Seco F; Lozano-Hernández MC; Seco-Segura ÁM; Moreno-Fernández J; Muñoz-Cazallas PA; Ferreiro-Vicario C; Sánchez-Covisa MA
Enferm Clin; 2013; 23(3):96-102. PubMed ID: 23755944
[TBL] [Abstract][Full Text] [Related]
9. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
[TBL] [Abstract][Full Text] [Related]
10. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.
Cohen N; Minshall ME; Sharon-Nash L; Zakrzewska K; Valentine WJ; Palmer AJ
Pharmacoeconomics; 2007; 25(10):881-97. PubMed ID: 17887808
[TBL] [Abstract][Full Text] [Related]
11. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
[TBL] [Abstract][Full Text] [Related]
12. Availability of and access to continuous subcutaneous insulin infusion therapy for adults with type 1 diabetes in Ireland.
Gajewska KA; Biesma R; Bennett K; Sreenan S
Acta Diabetol; 2020 Jul; 57(7):875-882. PubMed ID: 32124077
[TBL] [Abstract][Full Text] [Related]
13. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of the Continuous Subcutaneous Insulin Infusion-Related Quality-of-Life (CSII-QOL) Scale.
Sakane N; Murata T; Tone A; Kato K; Kimura M; Kawashima S; Sawaki H; Hirota Y; Okada A; Kuroda A; Matsuhisa M; Watanabe T; Suganuma A; Nirengi S; Toyoda M
Diabetes Technol Ther; 2020 Mar; 22(3):216-221. PubMed ID: 31638420
[No Abstract] [Full Text] [Related]
15. [Indications for the use of continuous subcutaneous insulin infusion in pediatric patients with type 1 diabetes mellitus].
Espejel-Huerta D; Antillón-Ferreira CA; Iglesias-Leboreiro J; Bernárdez-Zapata I; Martínez-Ramos Méndez A; Rendón-Macías ME
Rev Med Inst Mex Seguro Soc; 2016; 54(1):64-9. PubMed ID: 26820201
[TBL] [Abstract][Full Text] [Related]
16. Young people with type 1 diabetes mellitus: Attitudes, perceptions, and experiences of diabetes management and continuous subcutaneous insulin infusion therapy.
Perry L; James S; Steinbeck K; Dunbabin J; Lowe J
J Eval Clin Pract; 2017 Jun; 23(3):554-561. PubMed ID: 28052468
[TBL] [Abstract][Full Text] [Related]
17. Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Results of an online survey.
Taleb N; Messier V; Ott-Braschi S; Ardilouze JL; Rabasa-Lhoret R
Diabetes Res Clin Pract; 2018 Oct; 144():42-50. PubMed ID: 30077691
[TBL] [Abstract][Full Text] [Related]
18. The Choice Should Be Yours: Diabetes-Related Distress by Insulin Delivery Method for People with Type 1 Diabetes.
Wardian JL; True MW; Folaron I; Colburn J; Tate JM; Beckman DJ
Diabetes Technol Ther; 2020 Jan; 22(1):42-47. PubMed ID: 31418594
[No Abstract] [Full Text] [Related]
19. Continuous Subcutaneous Insulin Infusion in Neonates and Infants Below 1 Year: Analysis of Initial Bolus and Basal Rate Based on the Experiences from the German Working Group for Pediatric Pump Treatment.
Kapellen TM; Heidtmann B; Lilienthal E; Rami-Merhar B; Engler-Schmidt C; Holl RW
Diabetes Technol Ther; 2015 Dec; 17(12):872-9. PubMed ID: 26509360
[TBL] [Abstract][Full Text] [Related]
20. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
